HUE044928T2 - Ketamin orális dózisformája - Google Patents

Ketamin orális dózisformája

Info

Publication number
HUE044928T2
HUE044928T2 HUE15715764A HUE044928T2 HU E044928 T2 HUE044928 T2 HU E044928T2 HU E15715764 A HUE15715764 A HU E15715764A HU E044928 T2 HUE044928 T2 HU E044928T2
Authority
HU
Hungary
Prior art keywords
ketamine
dosage form
oral dosage
oral
dosage
Prior art date
Application number
Other languages
English (en)
Inventor
Sascha Manthei
Helene Rey
Marc Fischer
Olaf Mundszinger
Original Assignee
Develco Pharma Schweiz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Develco Pharma Schweiz Ag filed Critical Develco Pharma Schweiz Ag
Publication of HUE044928T2 publication Critical patent/HUE044928T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUE15715764 2014-04-17 2015-04-16 Ketamin orális dózisformája HUE044928T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14165057 2014-04-17

Publications (1)

Publication Number Publication Date
HUE044928T2 true HUE044928T2 (hu) 2019-11-28

Family

ID=50486823

Family Applications (3)

Application Number Title Priority Date Filing Date
HUE17186636A HUE060851T2 (hu) 2014-04-17 2015-04-16 Ketamin orális dózisformája
HUE15715764 HUE044928T2 (hu) 2014-04-17 2015-04-16 Ketamin orális dózisformája
HUE17186622A HUE051264T2 (hu) 2014-04-17 2015-04-16 Ketamin orális dózisformája

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE17186636A HUE060851T2 (hu) 2014-04-17 2015-04-16 Ketamin orális dózisformája

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE17186622A HUE051264T2 (hu) 2014-04-17 2015-04-16 Ketamin orális dózisformája

Country Status (8)

Country Link
US (3) US10335379B2 (hu)
EP (4) EP3287124B1 (hu)
DK (2) DK3272338T3 (hu)
ES (3) ES2743699T3 (hu)
FI (1) FI3287124T3 (hu)
HU (3) HUE060851T2 (hu)
PL (3) PL3131533T3 (hu)
WO (1) WO2015158854A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201802104QA (en) 2013-03-15 2018-05-30 Janssen Pharmaceutica Nv Pharmaceutical composition of s-ketamine hydrochloride
US20150118300A1 (en) 2013-10-31 2015-04-30 Cima Labs Inc. Immediate Release Abuse-Deterrent Granulated Dosage Forms
PL3131533T3 (pl) * 2014-04-17 2019-12-31 Develco Pharma Schweiz Ag Doustna postać dawkowania ketaminy
CA2961208A1 (en) 2014-09-15 2016-03-24 Janssen Pharmaceutica Nv Val66met (snp rs6265) genotype specific dosing regimens and methods for the treatment of depression
CA3020681A1 (en) 2016-04-11 2017-10-19 Clexio Biosciences Ltd. Deuterated ketamine derivatives
US11723883B2 (en) 2017-06-23 2023-08-15 Ketabon Gmbh Hydroxynorketamine for the use in the treatment of depression
US20200009081A1 (en) 2017-09-13 2020-01-09 Janssen Pharmaceutica N.V. Delivery Of Esketamine For The Treatment Of Depression
US11471415B2 (en) 2017-10-10 2022-10-18 Douglas Pharmaceuticals, Ltd. Extended release pharmaceutical formulation and methods of treatment
US10441544B2 (en) 2017-10-10 2019-10-15 Douglas Pharmaceuticals, Ltd. Extended release pharmaceutical formulation
US10869838B2 (en) 2017-10-10 2020-12-22 Douglas Pharmaceuticals, Ltd. Extended release pharmaceutical formulation
KR20240011237A (ko) 2017-12-22 2024-01-25 얀센 파마슈티카 엔브이 우울증 치료를 위한 에스케타민
CA3103440A1 (en) 2018-06-27 2020-01-02 Clexio Biosciences Ltd. Method of treating major depressive disorder
JP2022504036A (ja) 2018-10-05 2022-01-13 クレキシオ バイオサイエンシーズ エルティーディー． 大うつ病性障害を治療するためのエスケタミンの投与計画
CA3131929A1 (en) 2019-03-05 2020-09-10 Janssen Pharmaceuticals, Inc. Esketamine for the treatment of depression
US11324707B2 (en) 2019-05-07 2022-05-10 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
GB2596592A (en) 2020-07-03 2022-01-05 Alkaloid Ad Skopje Pharmaceutical formulation
CN112263572A (zh) * 2020-11-17 2021-01-26 厦门大学附属翔安医院 右旋***在制备治疗脱髓鞘疾病药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US5612059A (en) 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5798119A (en) 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
EP1103256A1 (de) 1999-11-26 2001-05-30 Claudius Dr. med. Böck Verwendung von Ketamin zur Behandlung von neuroendokriner Immundysfunktion und algogenem Psychosyndrom
AU2001276608A1 (en) 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20100291205A1 (en) * 2007-01-16 2010-11-18 Egalet A/S Pharmaceutical compositions and methods for mitigating risk of alcohol induced dose dumping or drug abuse
DE102007009888A1 (de) 2007-02-28 2008-09-04 Hermann, Holger Lars, Dr. Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
CN101765582A (zh) 2007-04-26 2010-06-30 奥斯拜客斯制药有限公司 氘标记的***
US20120225949A1 (en) * 2009-08-14 2012-09-06 Demitri Papalos Compositions and methods for treating bipolar disorder
WO2014020155A1 (en) * 2012-08-02 2014-02-06 Clinpharm Reform Gmbh Oral transmucosal adminstration forms of s-ketamine
CA2922507C (en) * 2013-08-26 2022-07-05 Amorsa Therapeutics, Inc. Single-layer oral dose of neuro-attenuating ketamine
PL3131533T3 (pl) * 2014-04-17 2019-12-31 Develco Pharma Schweiz Ag Doustna postać dawkowania ketaminy

Also Published As

Publication number Publication date
EP3287124B1 (en) 2022-11-30
EP3287124A1 (en) 2018-02-28
ES2935800T3 (es) 2023-03-10
US20210386691A1 (en) 2021-12-16
EP3272338A1 (en) 2018-01-24
DK3131533T3 (da) 2019-09-16
FI3287124T3 (fi) 2023-01-13
PL3131533T3 (pl) 2019-12-31
ES2743699T3 (es) 2020-02-20
US10335379B2 (en) 2019-07-02
EP4180030A1 (en) 2023-05-17
PL3287124T3 (pl) 2023-02-20
US20170035707A1 (en) 2017-02-09
PL3272338T3 (pl) 2021-01-11
HUE060851T2 (hu) 2023-04-28
US20190290600A1 (en) 2019-09-26
US11103467B2 (en) 2021-08-31
EP3272338B1 (en) 2020-09-09
EP3131533B1 (en) 2019-06-05
EP3131533A1 (en) 2017-02-22
HUE051264T2 (hu) 2021-03-01
DK3272338T3 (da) 2020-11-02
WO2015158854A1 (en) 2015-10-22
ES2829279T3 (es) 2021-05-31

Similar Documents

Publication Publication Date Title
IL287437A (en) Flavociclib solid dosage forms
HUE044928T2 (hu) Ketamin orális dózisformája
ZA201700301B (en) Solid oral dosage form of lipophilic compounds
IL249946B (en) High Dose Strength Rocaprib Tablets
GB201419257D0 (en) Pharmaceutical compositions
GB201618482D0 (en) Pharmaceutical compositions
DK3229816T3 (en) Proton-bindende polymerer til oral administration
IL249553A0 (en) Pharmaceutical preparations
ZA201700843B (en) Oral pharmaceutical composition of isotretinoin
IL250817A0 (en) pharmaceutical preparations
IL249151A0 (en) A preparation for oral administration
HRP20181406T1 (hr) Farmaceutski dozni oblici
EP3167870C0 (en) TAMPER-PROOF ORAL DOSAGE FORM
ZA201509174B (en) An oral medicinal composition
GB201415811D0 (en) Solid dosage form production
SG2014014872A (en) Pharmaceutical compositions
GB201408432D0 (en) Pharmaceutical compositions